Gray, PhD, a central figure in ECOG-ACRIN Cancer Research Group for more than 25 years, has retired from his position as Group Statistician, Therapeutics. Dr. Gray will continue to serve the group in ...

The goal of this paper is to provide guidelines for appropriate questions that should be considered early in the design stage to facilitate the interactions between clinical and statistical teams and ...

In the information age, bridging the gap between data and clinical application is crucial. The Center for Clinical and Translational Science (CCTS) is making significant investments in this area. Over ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Trial Evaluates Solution to Sample Tampering in Point-of-Care Urine Drug Testing The EvoClinical team is proud to ...

Statistical fragility refers to the vulnerability of clinical trial results to minor changes in event outcomes. The fragility index quantifies this vulnerability by determining the minimum number of ...

Looking to get into statistical programming but lack industry experience? We spoke with several statistical programmers from diverse backgrounds, and one thing became clear—there’s no single path to ...